AMY MUNRO: Open Payments
NPI 1366447765 · CHEEKTOWAGA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,475 in 239 payments from 24 companies in 2025. Trend: 2023 $3,829 · 2024 $3,036 · 2025 $4,475
Food & beverage: $4,453Education: $23
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 36 | $662 |
| Lilly USA, LLC | 25 | $487 |
| AstraZeneca Pharmaceuticals LP | 16 | $461 |
| Novo Nordisk Inc | 29 | $410 |
| ABBVIE INC. | 20 | $346 |
| Corcept Therapeutics | 17 | $294 |
| Currax Pharmaceuticals LLC | 21 | $257 |
| Exact Sciences Corporation | 8 | $253 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $209 |
| Axsome Therapeutics, Inc. | 5 | $192 |
Products named: XIFAXAN, Korlym, VRAYLAR, CONTRAVE, The Cologuard Plus Collection Kit, MOUNJARO, BREZTRI, Ozempic.
Industry payments across NY — which companies pay providers there.
